Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Smart sensors may predict lung infections before symptoms start

NCT ID NCT07289100

Knowledge-focused Sponsor: Papworth Hospital NHS Foundation Trust Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing whether wearable sensors that track things like heart rate and breathing can detect changes during a chest infection in adults with cystic fibrosis or bronchiectasis. Researchers will monitor 50 patients who are starting intravenous antibiotics for a lung infection. The goal is to see if sensor data changes between the start and end of treatment, which could help develop early warning systems for future infections.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to a way to catch chest infections earlier using simple wearable sensors, potentially reducing hospital stays.
What could go wrong
This is a small, early observational study (50 people) that only measures changes during treatment. It does not test any new treatment or device for home use yet.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 50 people

The number the study aims to enrol. It can still change while the study runs.

Started

Sep 2025

Expected to finish

Apr 2026

An estimate. End dates often move.

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients admitted under the specialist care of Royal Papworth Hospital Foundation Trust, Cambridge, UK

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * ≥ 18 years old * Diagnosis of CF based on genetic testing and /or sweat chloride levels or CT confirmed diagnosis of non-CF bronchiectasis * Under the care of Royal Papworth Hospital * Starting IV antibiotics for treatment of APE as defined by the Hill Criteria ² Exclusion Criteria: * Patients unable to provide written informed consent * Lung transplant recipients or on lung transplant waiting list * Use of long-term oxygen therapy (LTOT) or non-invasive ventilation to manage respiratory failure * Patients unwilling to consent to their link anonymised data from home monitoring being used for research * Considered unsuitable for home monitoring in the opinion of the investigator * Patients being admitted for elective antibiotic treatment (i.e. not being admitted for acute APE treatment)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bronchiectasis adult are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

bronchiectasis cystic fibrosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Bronchiectasis adult Cystic fibrosis (CF)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Royal Papworth Hospital NHS Foundation Trust

    RECRUITING

    Cambridge, Cambridgeshire, CB2 0AY, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.